DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
SLV-334
2
Small molecule
Investigational
Unknown
Unknown
Brain Injuries
Unknown
SLV-334
×
Maximum Phase:
2
First Approval:
None
UNII:
3613ZP748K
Molecule Type:
Small molecule
Molecular Formula:
C33H36N2O6
Molecular Weight:
556.66
AlogP:
4.97
PSA:
124.01
HBD:
3.0
HBA:
#RotB:
10.0
Source:
CALCIUM PHOSPHATE, TRIBASIC
2
Small molecule
Investigational
Unknown
Unknown
Dental Caries
Unknown
CALCIUM PHOSPHATE, TRIBASIC
×
Maximum Phase:
2
First Approval:
None
UNII:
K4C08XP666
Molecule Type:
Small molecule
Molecular Formula:
Ca3O8P2
Molecular Weight:
310.17
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BIIB061
2
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis
Unknown
BIIB061
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAURINE
2
Small molecule
Investigational
Unknown
Unknown
Homocystinuria; Multiple Sclerosis; Bipolar Disorder; Diabetes Mellitus, Type 2; Mental Disorders; Hypertension
Unknown
TAURINE
×
Maximum Phase:
2
First Approval:
None
UNII:
1EQV5MLY3D
Molecule Type:
Small molecule
Molecular Formula:
C2H7NO3S
Molecular Weight:
125.15
AlogP:
-1.17
PSA:
80.39
HBD:
2.0
HBA:
#RotB:
2.0
Source:
LX-2931
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Unknown
LX-2931
×
Maximum Phase:
2
First Approval:
None
UNII:
C5AGI979T7
Molecule Type:
Small molecule
Molecular Formula:
C9H15N3O5
Molecular Weight:
245.24
AlogP:
-1.64
PSA:
142.19
HBD:
6.0
HBA:
#RotB:
5.0
Source:
PLOVAMER ACETATE
2
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis, Relapsing-Remitting
HLA class II histocompatibility antigen, DRB1-15 beta chain modulator
PLOVAMER ACETATE
×
Maximum Phase:
2
First Approval:
None
UNII:
5511VZ6NRQ
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDEGLITAZAR
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus
Peroxisome proliferator-activated receptor agonist
INDEGLITAZAR
×
Maximum Phase:
2
First Approval:
None
UNII:
JMC809G4ZH
Molecule Type:
Small molecule
Molecular Formula:
C19H19NO6S
Molecular Weight:
389.43
AlogP:
2.91
PSA:
94.83
HBD:
1.0
HBA:
#RotB:
7.0
Source:
FUCOXANTHIN
2
Small molecule
Investigational
Unknown
Unknown
Metabolic Syndrome
Unknown
FUCOXANTHIN
×
Maximum Phase:
2
First Approval:
None
UNII:
06O0TC0VSM
Molecule Type:
Small molecule
Molecular Formula:
C40H56O6
Molecular Weight:
632.88
AlogP:
8.14
PSA:
96.36
HBD:
2.0
HBA:
#RotB:
10.0
Source:
RILZABRUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Immunoglobulin G4-Related Disease; Pemphigus; Purpura, Thrombocytopenic, Idiopathic
Tyrosine-protein kinase BTK inhibitor
RILZABRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
5G1WE425BI
Molecule Type:
Small molecule
Molecular Formula:
C36H40FN9O3
Molecular Weight:
665.77
AlogP:
4.42
PSA:
138.66
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ASM-024
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
Muscarinic acetylcholine receptor M1 antagonist
ASM-024
×
Maximum Phase:
2
First Approval:
None
UNII:
R67KC9COEN
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CAPRAVIRINE
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
CAPRAVIRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
VHC779598X
Molecule Type:
Small molecule
Molecular Formula:
C20H20Cl2N4O2S
Molecular Weight:
451.38
AlogP:
5.5
PSA:
83.03
HBD:
1.0
HBA:
#RotB:
7.0
Source:
AFEGOSTAT
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AFEGOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
G23AP190YS
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO3
Molecular Weight:
147.17
AlogP:
-2.08
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
1.0
Source:
TROXACITABINE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia
DNA polymerase (alpha/delta/epsilon) inhibitor
TROXACITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
60KQZ0388Y
Molecule Type:
Small molecule
Molecular Formula:
C8H11N3O4
Molecular Weight:
213.19
AlogP:
-1.31
PSA:
99.6
HBD:
2.0
HBA:
#RotB:
2.0
Source:
NESBUVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Unknown
NESBUVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
EYK815W3Z8
Molecule Type:
Small molecule
Molecular Formula:
C22H23FN2O5S
Molecular Weight:
446.5
AlogP:
3.23
PSA:
99.85
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TAK-954
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TAK-954
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VX-702
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
MAP kinase p38 alpha inhibitor
VX-702
×
Maximum Phase:
2
First Approval:
None
UNII:
527E7SK68P
Molecule Type:
Small molecule
Molecular Formula:
C19H12F4N4O2
Molecular Weight:
404.32
AlogP:
3.62
PSA:
102.31
HBD:
2.0
HBA:
#RotB:
4.0
Source:
MSDC-0160
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MSDC-0160
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENCALERET
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ENCALERET
×
Maximum Phase:
2
First Approval:
None
UNII:
EF8081AQ6G
Molecule Type:
Small molecule
Molecular Formula:
C29H33ClFNO4
Molecular Weight:
514.04
AlogP:
6.2
PSA:
78.79
HBD:
3.0
HBA:
#RotB:
11.0
Source:
T-817
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
T-817
×
Maximum Phase:
2
First Approval:
None
UNII:
QY49O94S2W
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO2S
Molecular Weight:
291.42
AlogP:
2.53
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
7.0
Source:
AMELUBANT
2
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis; Arthritis, Rheumatoid; Asthma; Pulmonary Disease, Chronic Obstructive
Leukotriene B4 receptor 1 antagonist
AMELUBANT
×
Maximum Phase:
2
First Approval:
None
UNII:
E0018IF0K4
Molecule Type:
Small molecule
Molecular Formula:
C33H34N2O5
Molecular Weight:
538.64
AlogP:
6.95
PSA:
100.87
HBD:
3.0
HBA:
#RotB:
10.0
Source:
GRC-17536
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Neuropathies
Transient receptor potential cation channel subfamily A member 1 antagonist
GRC-17536
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GTX-758
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Estrogen receptor alpha agonist
GTX-758
×
Maximum Phase:
2
First Approval:
None
UNII:
406GR1485Z
Molecule Type:
Small molecule
Molecular Formula:
C19H13F2NO3
Molecular Weight:
341.31
AlogP:
4.35
PSA:
60.77
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PIPERINE
2
Small molecule
Investigational
Unknown
Unknown
Deglutition Disorders; Pain
Unknown
PIPERINE
×
Maximum Phase:
2
First Approval:
None
UNII:
U71XL721QK
Molecule Type:
Small molecule
Molecular Formula:
C17H19NO3
Molecular Weight:
285.34
AlogP:
3.0
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
3.0
Source:
JNJ-37822681
2
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Dopamine D2 receptor antagonist
JNJ-37822681
×
Maximum Phase:
2
First Approval:
None
UNII:
GJB2URS7NJ
Molecule Type:
Small molecule
Molecular Formula:
C17H17F5N4
Molecular Weight:
372.34
AlogP:
3.85
PSA:
41.05
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NEVANIMIBE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Cushing Syndrome
Unknown
NEVANIMIBE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
TK694ZFS57
Molecule Type:
Small molecule
Molecular Formula:
C27H40ClN3O
Molecular Weight:
458.09
AlogP:
6.63
PSA:
44.37
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PELITREXOL
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Colorectal Neoplasms; Lung Neoplasms
Unknown
PELITREXOL
×
Maximum Phase:
2
First Approval:
None
UNII:
DHT6E8M4KP
Molecule Type:
Small molecule
Molecular Formula:
C20H25N5O6S
Molecular Weight:
463.52
AlogP:
0.99
PSA:
187.5
HBD:
6.0
HBA:
#RotB:
9.0
Source:
AR-12286
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AR-12286
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986142
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis; Arthritis, Rheumatoid
Tyrosine-protein kinase BTK inhibitor
BMS-986142
×
Maximum Phase:
2
First Approval:
None
UNII:
PJX9GH268R
Molecule Type:
Small molecule
Molecular Formula:
C32H30F2N4O4
Molecular Weight:
572.61
AlogP:
4.4
PSA:
123.11
HBD:
3.0
HBA:
#RotB:
4.0
Source:
AMG-208
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms, Castration-Resistant
Hepatocyte growth factor receptor inhibitor
AMG-208
×
Maximum Phase:
2
First Approval:
None
UNII:
Y2SR66P7VM
Molecule Type:
Small molecule
Molecular Formula:
C22H17N5O2
Molecular Weight:
383.41
AlogP:
3.93
PSA:
74.43
HBD:
0.0
HBA:
#RotB:
5.0
Source:
ITACITINIB ADIPATE
2
Small molecule
Investigational
Unknown
Unknown
Bronchiolitis Obliterans
Unknown
ITACITINIB ADIPATE
×
Maximum Phase:
2
First Approval:
None
UNII:
XZG407XE0Y
Molecule Type:
Small molecule
Molecular Formula:
C32H33F4N9O5
Molecular Weight:
699.67
AlogP:
3.6
PSA:
119.62
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CAPESEROD
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Serotonin 4 (5-HT4) receptor partial agonist
CAPESEROD
×
Maximum Phase:
2
First Approval:
None
UNII:
8163770L8P
Molecule Type:
Small molecule
Molecular Formula:
C23H25ClN4O4
Molecular Weight:
456.93
AlogP:
3.39
PSA:
95.75
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ALBACONAZOLE
2
Small molecule
Investigational
Unknown
Unknown
Tinea Pedis; Vulvovaginitis
Lanosterol 14-alpha demethylase inhibitor
ALBACONAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
YDW24Y8IAB
Molecule Type:
Small molecule
Molecular Formula:
C20H16ClF2N5O2
Molecular Weight:
431.83
AlogP:
3.07
PSA:
85.83
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CAPADENOSON
2
Small molecule
Investigational
Unknown
Unknown
Angina, Stable; Atrial Fibrillation
Adenosine A1 receptor partial agonist
CAPADENOSON
×
Maximum Phase:
2
First Approval:
None
UNII:
O519NVW73R
Molecule Type:
Small molecule
Molecular Formula:
C25H18ClN5O2S2
Molecular Weight:
520.04
AlogP:
5.51
PSA:
128.84
HBD:
2.0
HBA:
#RotB:
8.0
Source:
FUNAPIDE
2
Small molecule
Investigational
Unknown
Unknown
Erythromelalgia; Neuralgia, Postherpetic; Osteoarthritis, Knee
Unknown
FUNAPIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
A5595LHJ2L
Molecule Type:
Small molecule
Molecular Formula:
C22H14F3NO5
Molecular Weight:
429.35
AlogP:
4.25
PSA:
61.14
HBD:
0.0
HBA:
#RotB:
2.0
Source:
P276-00
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
P276-00
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
120
121
122
123
124
125
126
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA